Clinical Trials Browser

Phase 3 × INDUSTRY × selinexor × Clear all

NCT03555422 2026-04-13

ENGOT-EN5

Phase 3 Completed

Genital Diseases, Neoplasms, Neoplasms by Site, Uterine Diseases, Uterine Neoplasms, Endometrial Neoplasms

NCT04562389 2026-04-09

SENTRY

Phase 3 Active not recruiting

Myeloproliferative Disorders, Primary Myelofibrosis

NCT06158841 2026-03-13

CERVINO

Phase 3 Recruiting

Multiple Myeloma

NCT07138209 2026-02-27

A Study Comparing QLS32015 Monotherapy Versus Pomalidomide, Dexamethasone (Pd) or Selinexor, Dexamethasone (Sd) in Participants With Relapsed or Refractory Multiple Myeloma

Phase 3 Recruiting

Multiple Myeloma, Recurrence

NCT05611931 2026-02-02

XPORT-EC-042

Phase 3 Recruiting

Endometrial Neoplasms

NCT07011056 2025-09-19

A Phase III Clinical Study of Purinostat Mesylate for Injection in Patients With Diffuse Large B-cell Lymphoma

Phase 3 Recruiting

Recurrence, Lymphoma, Large B-Cell, Diffuse

NCT03110562 2024-08-21

BOSTON

Phase 3 Completed

402 enrolled 22 charts 3 FDA

Multiple Myeloma, Recurrence